Genetic diversity of enteric viruses responsible of gastroenteritis in urban and rural Burkina Faso.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 01 11 2023
accepted: 20 05 2024
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 8 7 2024
Statut: epublish

Résumé

Viral gastrointestinal infections remain a major public health concern in developing countries. In Burkina Faso, there are very limited updated data on the circulating viruses and their genetic diversity. This study investigates the detection rates and characteristics of rotavirus A (RVA), norovirus (NoV), sapovirus (SaV) and human astrovirus (HAstV) in patients of all ages with acute gastrointestinal infection in urban and rural areas. From 2018 to 2021, stool samples from 1,295 patients with acute gastroenteritis were collected and screened for RVA, NoV, SaV and HAstV. Genotyping and phylogenetic analyses were performed on a subset of samples. At least one virus was detected in 34.1% of samples. NoV and SaV were predominant with detection rates of respectively 10.5 and 8.8%. We identified rare genotypes of NoV GII, RVA and HAstV, recombinant HAstV strains and a potential zoonotic RVA transmission event. We give an up-to-date epidemiological picture of enteric viruses in Burkina Faso, showing a decrease in prevalence but a high diversity of circulating strains. However, viral gastroenteritis remains a public health burden, particularly in pediatric settings. Our data advocate for the implementation of routine viral surveillance and updated management algorithms for diarrheal disease.

Sections du résumé

BACKGROUND BACKGROUND
Viral gastrointestinal infections remain a major public health concern in developing countries. In Burkina Faso, there are very limited updated data on the circulating viruses and their genetic diversity.
OBJECTIVES OBJECTIVE
This study investigates the detection rates and characteristics of rotavirus A (RVA), norovirus (NoV), sapovirus (SaV) and human astrovirus (HAstV) in patients of all ages with acute gastrointestinal infection in urban and rural areas.
STUDY DESIGN & METHODS METHODS
From 2018 to 2021, stool samples from 1,295 patients with acute gastroenteritis were collected and screened for RVA, NoV, SaV and HAstV. Genotyping and phylogenetic analyses were performed on a subset of samples.
RESULTS RESULTS
At least one virus was detected in 34.1% of samples. NoV and SaV were predominant with detection rates of respectively 10.5 and 8.8%. We identified rare genotypes of NoV GII, RVA and HAstV, recombinant HAstV strains and a potential zoonotic RVA transmission event.
CONCLUSIONS CONCLUSIONS
We give an up-to-date epidemiological picture of enteric viruses in Burkina Faso, showing a decrease in prevalence but a high diversity of circulating strains. However, viral gastroenteritis remains a public health burden, particularly in pediatric settings. Our data advocate for the implementation of routine viral surveillance and updated management algorithms for diarrheal disease.

Identifiants

pubmed: 38976836
doi: 10.1371/journal.pntd.0012228
pii: PNTD-D-23-01364
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0012228

Informations de copyright

Copyright: © 2024 Badjo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Gastroenterology. 2009 May;136(6):1887-98
pubmed: 19457417
J Infect Public Health. 2022 Nov;15(11):1193-1211
pubmed: 36240530
J Med Virol. 2018 Sep;90(9):1453-1460
pubmed: 29718582
Infect Genet Evol. 2019 Apr;69:68-75
pubmed: 30641151
Infect Genet Evol. 2015 Jun;32:396-400
pubmed: 25847694
Expert Rev Mol Diagn. 2016 Jun;16(6):631-40
pubmed: 26986537
Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19353-8
pubmed: 22084114
PLoS One. 2016 Apr 26;11(4):e0151219
pubmed: 27115736
Virol J. 2015 May 15;12:78
pubmed: 25975198
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
BMC Public Health. 2017 Mar 21;17(1):274
pubmed: 28327111
Adv Virol. 2018 Sep 02;2018:5986549
pubmed: 30245718
BMC Infect Dis. 2021 Jan 4;21(1):1
pubmed: 33390160
J Infect Dis. 2022 Jun 15;225(12):2127-2136
pubmed: 33033832
Virol J. 2022 Dec 21;19(1):221
pubmed: 36544187
Infect Genet Evol. 2020 Aug;82:104313
pubmed: 32259662
Viruses. 2019 May 25;11(5):
pubmed: 31130647
Infect Genet Evol. 2020 Nov;85:104463
pubmed: 32693063
PLoS One. 2016 Apr 19;11(4):e0153652
pubmed: 27092779
J Infect Dis. 2022 Jun 15;225(12):2116-2126
pubmed: 32692812
Viruses. 2021 Mar 24;13(4):
pubmed: 33805214
Arch Virol. 2007;152(9):1743-9
pubmed: 17557132
JAMA Pediatr. 2018 Oct 1;172(10):958-965
pubmed: 30105384
Clin Microbiol Rev. 2015 Jan;28(1):32-53
pubmed: 25567221
Epidemiol Infect. 2020 Oct 01;148:e245
pubmed: 32998792
Sci Rep. 2019 Jul 10;9(1):9993
pubmed: 31292502
BMC Infect Dis. 2021 Jan 22;21(1):107
pubmed: 33482744
N Engl J Med. 1996 Oct 3;335(14):1022-8
pubmed: 8793926

Auteurs

Ange Oho Roseline Badjo (AOR)

Laboratory of Emerging and Re-emerging Pathogens, Nazi Boni University, Bobo Dioulasso, Burkina Faso.

Sandra Niendorf (S)

Robert Koch Institute, Berlin, Germany.

Sonja Jacobsen (S)

Robert Koch Institute, Berlin, Germany.

Arsène Zongo (A)

Centre MURAZ, Bobo-Dioulasso, Burkina Faso.

Andreas Mas Marques (A)

Robert Koch Institute, Berlin, Germany.

Ann Christin Vietor (AC)

Robert Koch Institute, Berlin, Germany.

Nongodo Firmin Kabore (NF)

Centre MURAZ, Bobo-Dioulasso, Burkina Faso.

Armel Poda (A)

Laboratory of Emerging and Re-emerging Pathogens, Nazi Boni University, Bobo Dioulasso, Burkina Faso.
Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
Department of Infectious Diseases, University Hospital Souro Sanou, Bobo-Dioulasso, Burkina Faso.

Satouro Arsène Some (SA)

Centre MURAZ, Bobo-Dioulasso, Burkina Faso.

Aminata Ouattara (A)

Laboratory of Emerging and Re-emerging Pathogens, Nazi Boni University, Bobo Dioulasso, Burkina Faso.
Bacteriology and Virology Department Souro Sanou University Hospital, Bobo-Dioulasso, Burkina Faso.

Soumeya Ouangraoua (S)

Centre MURAZ, Bobo-Dioulasso, Burkina Faso.

Grit Schubert (G)

Robert Koch Institute, Berlin, Germany.

Tim Eckmanns (T)

Robert Koch Institute, Berlin, Germany.

Fabian H Leendertz (FH)

Helmholtz Institute for One Health, Greifswald, Germany.

Essia Belarbi (E)

Robert Koch Institute, Berlin, Germany.

Abdoul-Salam Ouedraogo (AS)

Laboratory of Emerging and Re-emerging Pathogens, Nazi Boni University, Bobo Dioulasso, Burkina Faso.
Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
Bacteriology and Virology Department Souro Sanou University Hospital, Bobo-Dioulasso, Burkina Faso.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH